Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

26.43
BATS BZX Real-Time Price
As of 3:57pm ET
 +0.28 / +1.07%
Today’s Change
16.75
Today|||52-Week Range
41.77
-19.96%
Year-to-Date

Today’s Trading

Previous close26.15
Today’s open26.19
Day’s range25.97 - 26.50
Volume10,870
Average volume (3 months)275,316
Market cap$497.8M
Dividend yield--
Data as of 3:57pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)+127.22%
Earnings growth (this year)-75.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+236.98%
P/E ratio17.5
Price/Sales4.33
Price/Book2.07

Competitors

 Today’s
change
Today’s
% change
CYNACynapsus Therapeutic...-0.03-0.07%
OMEROmeros Corp+0.16+1.40%
NERVMinerva Neuroscience...-0.03-0.21%
FLXNFlexion Therapeutics...+1.30+7.43%
Data as of 3:57pm ET, 09/27/2016

Financials

Next reporting dateNovember 21, 2016
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$160.9M
Annual profit (last year)$79.0M
Net profit margin49.10%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class I Director
Jay R. Luly
CFO, Senior VP-Finance &
Administration
Paul J. Mellett
Corporate headquarters
Watertown, Massachusetts

Forecasts

Search for Jobs